SCHEMBL27166508

SCHEMBL27166508

Cn1c(=O)n(C2CCC(=O)NC2=O)c2cccc(CCCCCCCn3cc(CC(=O)O)cn3)c21

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.45
▸ DDB1 Q16531 18/20 0.45
▸ JAK2 O60674 1/20 0.36
▸ LPAR1 Q92633 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27166534 0.90 CRBN (0.41) CRBNDDB1JAK2
SCHEMBL27166496 0.85 CRBN (0.42) CRBNDDB1JAK2
SCHEMBL25123105 0.84 DDB1 (0.54) CRBNDDB1LPAR1
SCHEMBL29990946 0.84 DDB1 (0.54) CRBNDDB1LPAR1
SCHEMBL30990646 0.83 CRBN (0.54) CRBNDDB1
SCHEMBL30169156 0.83 CRBN (0.54) CRBNDDB1
SCHEMBL30169288 0.83 CRBN (0.54) CRBNDDB1
SCHEMBL22526772 0.83 CRBN (0.54) CRBNDDB1
SCHEMBL22526201 0.83 CRBN (0.54) CRBNDDB1
SCHEMBL25123384 0.83 CRBN (0.54) CRBNDDB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback